Chemical inhibitors of T2R42 include a diverse group of compounds that interact with the receptor to prevent the perception of bitterness. Denatonium Benzoate, known for its intense bitterness, can inhibit T2R42 by altering the receptor's conformation, effectively blocking its activation by other bitter compounds. Similarly, Quinine, a naturally occurring alkaloid, binds directly to the bitter taste receptor sites, which can obstruct the receptor's function. Naringin, a flavonoid prevalent in grapefruits, competitively binds to the active sites of T2R42, hindering activation by natural bitter ligands. Absinthin, another bitter substance, likely engages in negative allosteric modulation by binding to the receptor with high affinity, diminishing its ability to bind other bitter molecules.
Continuing the exploration of T2R42 inhibitors, Propylthiouracil (PTU) uses competitive inhibition, where it contends with other bitter ligands for the receptor's binding sites, thus preventing receptor activation. Parthenolide binds to the active sites of T2R42, inhibiting the receptor's response to bitterness. Amorolfine may alter the conformation of T2R42, reducing its interaction with bitter ligands. Similarly, Columbin and Amarogentin, both known for their bitterness, can inhibit T2R42 by binding with an affinity that surpasses other bitter molecules, thereby preventing receptor activation. Antibiotics like Erythromycin and Chloramphenicol interact with T2R42's active sites, leading to changes that inhibit the receptor's normal function. Lastly, Strychnine, a bitter and toxic alkaloid, inhibits T2R42 through competitive binding, which blocks the reception of bitter taste stimuli.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Denatonium benzoate | 3734-33-6 | sc-234525 sc-234525A sc-234525B sc-234525C sc-234525D | 1 g 5 g 25 g 100 g 250 g | $32.00 $47.00 $141.00 $473.00 $921.00 | ||
Denatonium Benzoate is known as one of the most bitter substances and can inhibit T2R42 by binding to the bitter taste receptor, leading to a change in the receptor's conformation and preventing its activation by other bitter compounds that would typically trigger a bitter taste response. | ||||||
Quinine | 130-95-0 | sc-212616 sc-212616A sc-212616B sc-212616C sc-212616D | 1 g 5 g 10 g 25 g 50 g | $79.00 $104.00 $166.00 $354.00 $572.00 | 1 | |
Quinine is an alkaloid that can act as an inhibitor of T2R42 by directly binding to the bitter taste receptor sites, which can block the receptor's function and prevent its activation by other bitter substances. | ||||||
Naringin | 10236-47-2 | sc-203443 sc-203443A | 25 g 50 g | $45.00 $101.00 | 7 | |
Naringin, a flavonoid found in grapefruits, possesses the capability to inhibit T2R42 by competitively binding to the receptor's active sites, thus hindering the receptor's activation by its natural bitter ligands. | ||||||
6-Propyl-2-thiouracil | 51-52-5 | sc-214383 sc-214383A sc-214383B sc-214383C | 10 g 25 g 100 g 1 kg | $37.00 $56.00 $224.00 $1997.00 | ||
Propylthiouracil, known for its bitter taste, can inhibit T2R42 through competitive inhibition, where it competes with other bitter ligands for the receptor's binding sites, thereby preventing receptor activation. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Parthenolide, a sesquiterpene lactone from feverfew, can inhibit T2R42 by binding to the receptor's active sites. This interaction can prevent the receptor's normal response to bitter compounds, inhibiting its functional activity. | ||||||
Erythromycin | 114-07-8 | sc-204742 sc-204742A sc-204742B sc-204742C | 5 g 25 g 100 g 1 kg | $57.00 $245.00 $831.00 $1331.00 | 4 | |
Erythromycin, an antibiotic that has a bitter taste, can inhibit T2R42 by directly interacting with the receptor, potentially leading to changes in the receptor's structure that prevent activation by other bitter substances. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $90.00 | 10 | |
Chloramphenicol, another antibiotic with a bitter component, can inhibit T2R42 by binding to the receptor's active sites, which can lead to an inhibition of the receptor's ability to be activated by bitter compounds. | ||||||